Adaptation of potentially preventable medication-related hospitalisation indicators for Indigenous populations in Australia using a modified Delphi technique

Abstract

ObjectivesOne of the outcomes of a medication review service is to identify and manage medication-related problems (MRPs). The most serious MRPs may result in hospitalisation, which could be preventable if appropriate processes of care were adopted. The aim of this study was to update and adapt a previously published set of clinical indicators for use in assessing the effectiveness of a medication review service tailored to meet the needs of Indigenous people, who experience some of the worst health outcomes of all Australians. i DesignA modified Delphi technique was used to: (i) identify additional indicators for consideration, (ii) assess whether the original indicators were relevant in the context of Indigenous health and (iii) reach consensus on a final set of indicators. Three rounds of rating were used via an anonymous online survey, with 70% agreement required for indicator inclusion.SettingThe indicators were designed for use in Indigenous primary care in Australia.ParticipantsThirteen panellists participated including medical specialists, general practice doctors, pharmacists and epidemiologists experienced in working with Indigenous patients.ResultsPanellists rated 101 indicators (45 from the original set and 57 newly identified). Of these, 41 were accepted unchanged, seven were rejected and the remainder were either modified before acceptance or merged with other indicators. A final set of 81 indicators was agreed.ConclusionsThis study provides a set of clinical indicators to be used as a primary outcome measure for medication review services for Indigenous people in Australia and as a prompt for pharmacists and doctors conducting medication reviews.Trial registration numberThe trial registration for the Indigenous Medication Review Service feasibility study is ACTRN12618000188235.

Risk of 30-day hospital readmission associated with medical conditions and drug regimens of polymedicated, older inpatients discharged home: a registry-based cohort study

“…Even though some studies have reported high numbers of readmissions among home-dwelling older patients for a variety of drugs,38 this health issue was mostly investigated using prospective or cross-sectional studies with small samples. More insight is needed into the patterns of drug-related hospital readmissions and risk factors in order to design better interventions for addressing ADEs 39 40.…”

Enhancing Patient Safety in Opioid Prescribing: A Systematic Review of Potential Indicators

“…The 48 included studies which reported at least one opioid-related prescribing indicator (2, 9, 24–69) were published during the period 2010-2019 (n=24)(13, 27, 28, 30–33, 35, 37–39, 41, 43, 45, 46, 49, 50, 54, 55, 57, 60, 63, 65, 66) followed by 2000-2009 (n=13) (9, 24, 29, 34, 42, 44, 48, 56, 58, 59, 62, 67, 68) and 2020-2022 (n=10) (2, 25, 26, 36, 40, 51–53, 61, 69) and only one published in 1990-1999 (47) (Table 2). .…”

Activating pharmacists to reduce the frequency of medication‐related problems (ACTMed): a stepped wedge cluster randomised trial

“…The incidence or prevalence of clinical indicators based on our findings in earlier studies 19‐21 were estimated using a tranche of Data for Decisions [Patron] data (Supporting Information, part 2) 22 . Further criteria for selecting clinical indicators were prevalence rates, the possibility of incorrect diagnoses, the availability of interventions that could be undertaken by qualified pharmacists and general practitioners, and other practical considerations.…”